SRX Health Solutions Inc (AMEX: SRXH) has a higher price-to-earnings ratio of 0.05x compared to its average ratio. SRXH has 36-month beta value of 0.90.
The public float for SRXH is 41.97M, and currently, short sellers hold a 14.51% ratio of that float. The average trading volume of SRXH on February 12, 2026 was 22.72M shares.
SRXH stock’s latest price update
SRX Health Solutions Inc (AMEX: SRXH)’s stock price has plunge by -16.24%relation to previous closing price of $0.16. Nevertheless, the company has seen a -3.53% plunge in its stock price over the last five trading sessions.
SRXH’s Market Performance
SRX Health Solutions Inc (SRXH) has experienced a -3.53% fall in stock performance for the past week, with a -32.88% drop in the past month, and a -36.39% drop in the past quarter. The volatility ratio for the week is 38.10%, and the volatility levels for the past 30 days are at 18.60% for SRXH. The simple moving average for the last 20 days is -11.47% for SRXH stock, with a simple moving average of -68.33% for the last 200 days.
SRXH Trading at -46.03% from the 50-Day Moving Average
After a stumble in the market that brought SRXH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -94.04% of loss for the given period.
Volatility was left at 18.60%, however, over the last 30 days, the volatility rate increased by 38.10%.
Stock Fundamentals for SRXH
Current profitability levels for the company are sitting at:
- -0.51% for the present operating margin
- 0.25% for the gross margin
The net margin for SRX Health Solutions Inc stands at 0.92%. The total capital return value is set at 5.29%. Equity return is now at value 37.38%, with 11.06% for asset returns.
Based on SRX Health Solutions Inc (SRXH), the company’s capital structure generated 0.92 points at debt to capital in total, while cash flow to debt ratio is standing at -0.12. The debt to equity ratio resting at 10.99. The interest coverage ratio of the stock is 11.14.
Currently, EBITDA for the company is -$11.0 million with net debt to EBITDA at -0.06. When we switch over and look at the enterprise to sales, we see a ratio of -0.15. The receivables turnover for the company is -12.8for trailing twelve months and the total asset turnover is -6.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.33.
Conclusion
To put it simply, SRX Health Solutions Inc (SRXH) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.